Successful Dose Reduction of Dupilumab in Patients With Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Successful Dose Reduction of Dupilumab in Atopic Dermatitis
Br J Dermatol 2023 Jan 20;[EPub Ahead of Print], MR Ardern-Jones, EE Buchanan, S Njungu, D O'DriscollFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.